Previous 10 | Next 10 |
Doximity, Inc. (DOCS) Q2 2023 Earnings Conference Call November 10, 2022 17:00 ET Company Participants Perry Gold - Head of Investor Relations Jeff Tangney - Co-Founder & Chief Executive Officer Anna Bryson - Chief Financial Officer Nate Gross - Co-Founde...
Doximity ( NYSE: DOCS ) is up 16% following its fiscal 2023 Q2 earnings beats and the digital platform's full-year revenue guidance included the consensus estimate. The company is projecting fiscal 2023 revenue of $424M-$432M. The consensus estimate is $426.36...
Doximity press release ( NYSE: DOCS ): Q2 Non-GAAP EPS of $0.17 beats by $0.01 . Revenue of $102.19M (+28.8% Y/Y) beats by $1.85M . Operating cash flow of $39.5 million, up 106% year-over-year FCF of $37.7 million, up 109% year-over-year. Adjusted EBITD...
Q2 total revenues of $102.2 million , up 29% year-over-year Q2 operating cash flow of $39.5 million, up 106% year-over-year Q2 free cash flow of $37.7 million, up 109% year-over-year Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. m...
Shares of Doximity (NYSE: DOCS) , a digital platform for healthcare professionals, fell 12.4% in October, according to data from S&P Global Intelligence . The stock ended September at $30.22. Doximity opened October at $30.40, falling to a monthly low of $24.15 on Oc...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its second quarter ended September 30, 2022 after market close on November 10, 2022. Doximity will host a conference call and webcast at 2:00 p.m...
Telehealth stocks have taken a beating this year. The takeaway for skeptical investors is that, with the pandemic ebbing, the need for telehealth will lessen. That's not necessarily the case, but that doesn't mean all telehealth companies will thrive. Since the beginning of the year, ...
Summary DOCS stock has been hit hard lately as the company is experiencing its first revenue growth slowdown. Management believes this is just a short-term pain due to the macro conditions and that higher growth will come back. I argue that even if they maintain the current gr...
Telehealth is one sector that investors have been particularly bearish on this year. The Global X Telemedicine & Digital Health ETF has fallen 33% since the start of 2022, which is notably worse than the S&P 500 's 24% decline over the same period. Despite promising growth o...
Doximity ( NYSE: DOCS ), which is currently down 9% in Wednesday afternoon trading, fell below its IPO price of $26 during the trading session. At its lowest, the share price reached $25, also a 52-week low. Trading is also heavy in the stock today. Normal daily vo...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...